Pimavanserin Tartrate
Overview
Pimavanserin Tartrate is an atypical antipsychotic that targets the serotonergic system and is used primarily for the treatment of Parkinson's disease psychosis. It functions by selectively antagonizing serotonin receptors and is notable for not influencing dopaminergic receptors.
API suppliers (6)
Suppliers of Pimavanserin Tartrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 6 suppliers.
3 of 6 hold a GMP certificate on record in the EU or UK registers
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA1 active DMF
- DASAMI LAB PRIVATE LTDIndia1 active DMF GMP on record
- Zydus Lifesciences LimitedIndia1 active DMF GMP on record
- JIANGSU TASLY DIYI PHARMACEUTICAL CO LTDChina1 active DMF
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
Therapeutic areas
Do you supply Pimavanserin Tartrate? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.